Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment

European Journal of Pharmacology

Volumn 638, Issue 1-3, 2010, Pages 134-141

  Pinlaor, Somchai ^a   Prakobwong, Suksanti ^a   Hiraku, Yusuke ^c   Pinlaor, Porntip ^a,b   Laothong, Umawadee ^a   Yongvanit, Puangrat ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

(Opisthorchis viverrini); Curcumin; Cytokine; Matrix metalloproteinase; Peribiliary fibrosis; Tissue inhibitor of metalloproteinase

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; CURCUMIN; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYPROLINE; INTERLEUKIN 1BETA; MATRILYSIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ACTIN; COLLAGEN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HAMSTER; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LONG TERM CARE; MALE; NONHUMAN; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; DRUG ADMINISTRATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; METABOLISM; PATHOLOGY;

ACTINS; ANIMALS; COLLAGEN; CRICETINAE; CURCUMIN; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION; HYDROXYPROLINE; INFLAMMATION; INTERLEUKIN-1BETA; LIVER CIRRHOSIS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASES; OPISTHORCHIASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953545289     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.018     Document Type: Article

References (36)

1. Bruck R., Ashkenazi M., Weiss S., Goldiner I., Shapiro H., Aeed H., Genina O., Helpern Z., Pines M. Prevention of liver cirrhosis in rats by curcumin. Liver Int. 2007, 27:373-383.
2. Chapman R.W. Risk factors for biliary tract carcinogenesis. Ann. Oncol. 1999, 10(Suppl 4):308-311.
3. Clark I.M., Swingler T.E., Sampieri C.L., Edwards D.R. The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 2008, 40:1362-1378.
4. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14:4491-4499.
5. Dooley S., Hamzavi J., Ciuclan L., Godoy P., Ilkavets I., Ehnert S., Ueberham E., Gebhardt R., Kanzler S., Geier A., Breitkopf K., Weng H., Mertens P.R. Hepatocyte-specific Smad7 expression attenuates TGF-β-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008, 135:642-659.
6. Elkins D.B., Mairiang E., Sithithaworn P., Mairiang P., Chaiyakum J., Chamadol N., Loapaiboon V., Haswell-Elkins M.R. Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans. Am. J. Trop. Med. Hyg. 1996, 55:295-301.
7. Farazi P.A., Zeisberg M., Glickman J., Zhang Y., Kalluri R., DePinho R.A. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice. Cancer Res. 2006, 66:6622-6627.
8. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
9. Goel A., Jhurani S., Aggarwal B.B. Multi-targeted therapy by curcumin: how spicy is it?. Mol. Nutr. Food Res. 2008, 52:1010-1030.
10. Hemmann S., Graf J., Roderfeld M., Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 2007, 46:955-975.
11. Hutadilok N., Ruenwongsa P. Liver collagen turnover in hamsters during infection by the human liver fluke, Opisthorchis viverrini. Mol. Biochem. Parasitol. 1983, 8:71-77.
12. IARC, Working Group. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr. Eval. Carcinog. Risks Hum. 1994, 61:121-175.
13. Jongsuksuntigul P., Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop. 2003, 88:229-232.
14. Kawanishi S., Hiraku Y., Pinlaor S., Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 2006, 387:365-372.
15. Kisseleva T., Brenner D.A. Hepatic stellate cells and the reversal of fibrosis. J. Gastroenterol. Hepatol. 2006, 21(Suppl 3):S84-S87.
16. Kitiyakara T., Chapman R.W. Chemoprevention and screening in primary sclerosing cholangitis. Postgrad. Med. J. 2008, 84:228-237.
17. Kunnumakkara A.B., Anand P., Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008, 269:199-225.
18. -δCt Method. Methods 2001, 25:402-408.
19. Mishima T., Tajima Y., Kuroki T., Kosaka T., Adachi T., Kitasato A., Tsuneoka N., Kitajima T., Kanematsu T. Chemopreventative effect of an inducible nitric oxide synthase inhibitor, ONO-1714, on inflammation-associated biliary carcinogenesis in hamsters. Carcinogenesis 2009, 30:1763-1767.
20. O'Connell M.A., Rushworth S.A. Curcumin: potential for hepatic fibrosis therapy?. Br. J. Pharmacol. 2008, 153:403-405.
21. Panchatcharam M., Miriyala S., Gayathri V.S., Suguna L. Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol. Cell. Biochem. 2006, 290:87-96.
22. Pinlaor S., Hiraku Y., Ma N., Yongvanit P., Semba R., Oikawa S., Murata M., Sripa B., Sithithaworn P., Kawanishi S. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 2004, 11:175-183.
23. Pinlaor S., Ma N., Hiraku Y., Yongvanit P., Semba R., Oikawa S., Murata M., Sripa B., Sithithaworn P., Kawanishi S. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7, 8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 2004, 25:1535-1542.
24. Pinlaor S., Yongvanit P., Hiraku Y., Ma N., Semba R., Oikawa S., Murata M., Sripa B., Sithithaworn P., Kawanishi S. 8-Nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem. Biophys. Res. Commun. 2003, 309:567-571.
25. Pinlaor S., Yongvanit P., Prakobwong S., Kaewsamut B., Khoontawad J., Pinlaor P., Hiraku Y. Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. Mol. Nutr. Food Res. 2009, 53:1316-1328.
26. Prakobwong S., Pinlaor S., Yongvanit P., Sithithaworn P., Pairojkul C., Hiraku Y. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int. J. Parasitol. 2009, 39:825-835.
27. Pungpak S., Sornmani S., Suntharasamai P., Vivatanasesth P. Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. Southeast Asian J. Trop. Med. Public Health 1989, 20:157-162.
28. Ridnour L.A., Windhausen A.N., Isenberg J.S., Yeung N., Thomas D.D., Vitek M.P., Roberts D.D., Wink D.A. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16898-16903.
29. Saowakontha S., Pipitgool V., Pariyanonda S., Tesana S., Rojsathaporn K., Intarakhao C. Field trials in the control of Opisthorchis viverrini with an integrated programme in endemic areas of northeast Thailand. Parasitology 1993, 106(Pt 3):283-288.
30. Shakibaei M., Schulze-Tanzil G., John T., Mobasheri A. Curcumin protects human chondrocytes from IL-1β-induced inhibition of collagen type II and β1-integrin expression and activation of caspase-3: an immunomorphological study. Ann. Anat. 2005, 187:487-497.
31. Sirica A.E. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005, 41:5-15.
32. Sriamporn S., Pisani P., Pipitgool V., Suwanrungruang K., Kamsa-ard S., Parkin D.M. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen. Northeast Thai. Trop. Med. Int. Health 2004, 9:588-594.
33. Sripa B., Kaewkes S. Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int. J. Parasitol. 2000, 30:735-740.
34. Upatham E.S., Viyanant V., Brockelman W.Y., Kurathong S., Lee P., Kraengraeng R. Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int. J. Parasitol. 1988, 18:643-649.
35. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 2007, 117:524-529.
36. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.